While Ozempic is a type-2 diabetes treatment and not officially approved as a weight loss drug, some physicians have prescribed it and a similar drug, Mounjaro after seeing benefits related to weight loss.
The loss of muscle mass is concerning because it is typically associated with the body aging and can lead to loss of balance, weakness and other side effects, according to Harvard Medical School.
Quick weight loss can also induce other conditions like sarcopenia and bone density issues, according to CBS. Patients taking the medications should combat the effects by engaging in strength workouts and adding more protein in their diet.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
